Search by Drug Name or NDC
NDC 00409-9302-20 Ropivacaine Hydrochloride 7.5 mg/mL Details
Ropivacaine Hydrochloride 7.5 mg/mL
Ropivacaine Hydrochloride is a EPIDURAL; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is ROPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 00409-9302 |
|---|---|
| Product ID | 0409-9302_f5cd7992-66a9-410a-a486-110cd85228a2 |
| Associated GPIs | 69100070102030 |
| GCN Sequence Number | 028224 |
| GCN Sequence Number Description | ropivacaine HCl/PF VIAL 7.5 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 46088 |
| HICL Sequence Number | 036674 |
| HICL Sequence Number Description | ROPIVACAINE HCL/PF |
| Brand/Generic | Generic |
| Proprietary Name | Ropivacaine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ROPIVACAINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; PERINEURAL |
| Active Ingredient Strength | 7.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | ROPIVACAINE HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090194 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-9302-20 (00409930220)
| NDC Package Code | 0409-9302-20 |
|---|---|
| Billing NDC | 00409930220 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-9302-20) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-9302-21) |
| Marketing Start Date | 2014-09-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |